{
    "organizations": [],
    "uuid": "eefdc3e6e21e97e6ade81f6a2958f35ef03b13f4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biovica-results-support-treatment/brief-biovica-results-support-treatment-efficacy-evaluation-with-divitum-idUSFWN1R90ZF",
    "ord_in_thread": 0,
    "title": "BRIEF-Biovica: ‍Results Support Treatment Efficacy Evaluation With DiviTum​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - BIOVICA INTERNATIONAL AB:\n* NEW POSITIVE RESULTS SUPPORT EARLY TREATMENT EVALUATION OF BREAST CANCER USING DIVITUM®\n* ‍RESULTS SUPPORT TREATMENT EFFICACY EVALUATION WITH DIVITUM​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-28T14:05:00.000+03:00",
    "crawled": "2018-03-29T15:45:09.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "biovica",
        "international",
        "ab",
        "new",
        "positive",
        "result",
        "support",
        "early",
        "treatment",
        "evaluation",
        "breast",
        "cancer",
        "using",
        "support",
        "treatment",
        "efficacy",
        "evaluation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}